Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 625

1.

Inter- and Intra-software Reproducibility of Computed Tomography Lung Density Measurements.

Kirby M, Hatt C, Obuchowski N, Humphries SM, Sieren J, Lynch DA, Fain SB; QIBA Lung Density Committee.

Med Phys. 2020 Mar 11. doi: 10.1002/mp.14130. [Epub ahead of print]

PMID:
32160310
2.

How does awareness of cognitive impairment impact motivation and treatment outcomes during cognitive remediation for schizophrenia?

Saperstein AM, Lynch DA, Qian M, Medalia A.

Schizophr Res. 2020 Mar 7. pii: S0920-9964(20)30103-1. doi: 10.1016/j.schres.2020.02.014. [Epub ahead of print]

PMID:
32156497
3.

Invited Commentary on "Quantitative CT Analysis of Diffuse Lung Disease".

Fain SB, Lynch DA, Hatt C.

Radiographics. 2020 Mar-Apr;40(2):E1-E3. doi: 10.1148/rg.2020200005. No abstract available.

PMID:
32125952
4.

Unexpected aetiology of chronic thrombocytopaenia.

Needs T, Lynch D.

J Clin Pathol. 2020 Feb 26. pii: jclinpath-2019-206289. doi: 10.1136/jclinpath-2019-206289. [Epub ahead of print] No abstract available.

PMID:
32102802
5.

Psychometric properties of the Friedreich Ataxia Rating Scale.

Rummey C, Corben LA, Delatycki MB, Subramony SH, Bushara K, Gomez CM, Hoyle JC, Yoon G, Ravina B, Mathews KD, Wilmot G, Zesiewicz T, Perlman S, Farmer JM, Lynch DR.

Neurol Genet. 2019 Oct 29;5(6):371. doi: 10.1212/NXG.0000000000000371. eCollection 2019 Dec.

6.

Luminal Plugging on Chest CT Scan: Association With Lung Function, Quality of Life, and COPD Clinical Phenotypes.

Okajima Y, Come CE, Nardelli P, Sonavane SK, Yen A, Nath HP, Terry N, Grumley SA, Ahmed A, Kligerman S, Jacobs K, Lynch DA, Make BJ, Silverman EK, Washko GR, San José Estépar R, Diaz AA.

Chest. 2020 Feb 1. pii: S0012-3692(20)30153-7. doi: 10.1016/j.chest.2019.12.046. [Epub ahead of print]

PMID:
32017932
7.

Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.

Pompe E, Strand M, van Rikxoort EM, Hoffman EA, Barr RG, Charbonnier JP, Humphries S, Han MK, Hokanson JE, Make BJ, Regan EA, Silverman EK, Crapo JD, Lynch DA; COPDGene Investigators.

Radiology. 2020 Apr;295(1):218-226. doi: 10.1148/radiol.2020191429. Epub 2020 Feb 4.

PMID:
32013794
8.

Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial ILD.

Salisbury ML, Hewlett JC, Ding G, Markin CR, Douglas K, Mason W, Guttentag A, Phillips JA 3rd, Cogan JD, Reiss S, Mitchell DB, Wu P, Young LR, Lancaster LH, Loyd JE, Humphries SM, Lynch DA, Kropski JA, Blackwell TS.

Am J Respir Crit Care Med. 2020 Feb 3. doi: 10.1164/rccm.201909-1834OC. [Epub ahead of print]

PMID:
32011901
9.

Correlation of Visual Quality of Life With Clinical and Visual Status in Friedreich Ataxia.

Afsharian P, Nolan-Kenney R, Lynch AE, Balcer LJ, Lynch DR.

J Neuroophthalmol. 2020 Jan 17. doi: 10.1097/WNO.0000000000000878. [Epub ahead of print]

PMID:
31977662
10.

Predictors of loss of ambulation in Friedreich's ataxia.

Rummey C, Farmer JM, Lynch DR.

EClinicalMedicine. 2020 Jan 8;18:100213. doi: 10.1016/j.eclinm.2019.11.006. eCollection 2020 Jan.

11.

Health related quality of life in Friedreich Ataxia in a large heterogeneous cohort.

Xiong E, Lynch AE, Corben LA, Delatycki MB, Subramony SH, Bushara K, Gomez CM, Hoyle JC, Yoon G, Ravina B, Mathews KD, Wilmot G, Zesiewicz T, Susan Perlman M, Farmer JM, Rummey C, Lynch DR.

J Neurol Sci. 2020 Mar 15;410:116642. doi: 10.1016/j.jns.2019.116642. Epub 2019 Dec 24.

PMID:
31901720
12.

Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.

Castaldi PJ, Boueiz A, Yun J, Estepar RSJ, Ross JC, Washko G, Cho MH, Hersh CP, Kinney GL, Young KA, Regan EA, Lynch DA, Criner GJ, Dy JG, Rennard SI, Casaburi R, Make BJ, Crapo J, Silverman EK, Hokanson JE; COPDGene Investigators.

Chest. 2019 Dec 28. pii: S0012-3692(19)34456-3. doi: 10.1016/j.chest.2019.11.039. [Epub ahead of print] Review.

PMID:
31887283
13.

Translation of adapting quantitative CT data from research to local clinical practice: validation evaluation of fully automated procedures to provide lung volumes and percent emphysema.

Leung KM, Curran-Everett D, Regan EA, Lynch DA, Jacobson FL.

J Med Imaging (Bellingham). 2020 Mar;7(2):022404. doi: 10.1117/1.JMI.7.2.022404. Epub 2019 Dec 10.

PMID:
31824985
14.

Deep Learning Enables Automatic Classification of Emphysema Pattern at CT.

Humphries SM, Notary AM, Centeno JP, Strand MJ, Crapo JD, Silverman EK, Lynch DA; Genetic Epidemiology of COPD (COPDGene) Investigators.

Radiology. 2020 Feb;294(2):434-444. doi: 10.1148/radiol.2019191022. Epub 2019 Dec 3.

PMID:
31793851
15.

Relationship between diffusion capacity and small airway abnormality in COPDGene.

Criner RN, Hatt CR, Galbán CJ, Kazerooni EA, Lynch DA, McCormack MC, Casaburi R, MacIntyre NR, Make BJ, Martinez FJ, Labaki WW, Curtis JL, Han MLK.

Respir Res. 2019 Dec 2;20(1):269. doi: 10.1186/s12931-019-1237-1.

16.

Using a spatial point process framework to characterize lung computed tomography scans.

Vestal BE, Carlson NE, Estépar RSJ, Fingerlin T, Ghosh D, Kechris K, Lynch D.

Spat Stat. 2019 Mar;29:243-267. doi: 10.1016/j.spasta.2018.12.003. Epub 2018 Dec 31.

17.

Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality.

Young KA, Regan EA, Han MK, Lutz SM, Ragland M, Castaldi PJ, Washko GR, Cho MH, Strand M, Curran-Everett D, Beaty TH, Bowler RP, Wan ES, Lynch DA, Make BJ, Silverman EK, Crapo JD, Hokanson JE, Kinney GL; COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2019 Nov;6(5):400-413. doi: 10.15326/jcopdf.6.5.2019.0150.

18.

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Lowe KE, Regan EA, Anzueto A, Austin E, Austin JHM, Beaty TH, Benos PV, Benway CJ, Bhatt SP, Bleecker ER, Bodduluri S, Bon J, Boriek AM, Boueiz AR, Bowler RP, Budoff M, Casaburi R, Castaldi PJ, Charbonnier JP, Cho MH, Comellas A, Conrad D, Costa Davis C, Criner GJ, Curran-Everett D, Curtis JL, DeMeo DL, Diaz AA, Dransfield MT, Dy JG, Fawzy A, Fleming M, Flenaugh EL, Foreman MG, Fortis S, Gebrekristos H, Grant S, Grenier PA, Gu T, Gupta A, Han MK, Hanania NA, Hansel NN, Hayden LP, Hersh CP, Hobbs BD, Hoffman EA, Hogg JC, Hokanson JE, Hoth KF, Hsiao A, Humphries S, Jacobs K, Jacobson FL, Kazerooni EA, Kim V, Kim WJ, Kinney GL, Koegler H, Lutz SM, Lynch DA, MacIntye NR Jr, Make BJ, Marchetti N, Martinez FJ, Maselli DJ, Mathews AM, McCormack MC, McDonald MN, McEvoy CE, Moll M, Molye SS, Murray S, Nath H, Newell JD Jr, Occhipinti M, Paoletti M, Parekh T, Pistolesi M, Pratte KA, Putcha N, Ragland M, Reinhardt JM, Rennard SI, Rosiello RA, Ross JC, Rossiter HB, Ruczinski I, San Jose Estepar R, Sciurba FC, Sieren JC, Singh H, Soler X, Steiner RM, Strand MJ, Stringer WW, Tal-Singer R, Thomashow B, Vegas Sánchez-Ferrero G, Walsh JW, Wan ES, Washko GR, Michael Wells J, Wendt CH, Westney G, Wilson A, Wise RA, Yen A, Young K, Yun J, Silverman EK, Crapo JD.

Chronic Obstr Pulm Dis. 2019 Nov;6(5):384-399. doi: 10.15326/jcopdf.6.5.2019.0149.

19.

Disease Progression Modeling in Chronic Obstructive Pulmonary Disease.

Young AL, Bragman FJS, Rangelov B, Han MK, Galbán CJ, Lynch DA, Hawkes DJ, Alexander DC, Hurst JR; COPDGene Investigators.

Am J Respir Crit Care Med. 2020 Feb 1;201(3):294-302. doi: 10.1164/rccm.201908-1600OC.

PMID:
31657634
20.

Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis.

Lynch D, O'Connor PM, Cotter PD, Hill C, Field D, Begley M.

PLoS One. 2019 Oct 16;14(10):e0223541. doi: 10.1371/journal.pone.0223541. eCollection 2019.

Supplemental Content

Loading ...
Support Center